Salvage of Donor Graft with Decitabine and Maintenance Post Allogeneic Stem Cell Transplantation in Myelodysplastic/Myeloproliferative Disease: A Case Report
- 31 August 2009
- journal article
- research article
- Published by Elsevier BV in Clinical Leukemia
- Vol. 3 (2), E22-E23
- https://doi.org/10.3816/clk.2009.n.010
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Evolution of decitabine developmentCancer, 2008
- Decitabine improves patient outcomes in myelodysplastic syndromesCancer, 2006
- Fifteen-Year Follow up of Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndromes Using Busulfan-Based Regimens.Blood, 2005
- A non‐randomised dose‐escalating phase II study of thalidomide for the treatment of patients with low‐risk myelodysplastic syndromes: the Thal‐SMD‐2000 trial of the Groupe Français des MyélodysplasiesBritish Journal of Haematology, 2005
- Antithymocyte globulin (ATG)-based therapy in patients with myelodysplastic syndromesLeukemia, 2003